Key result
Elevated pulse pressure drives CVD risk via arterial stiffness, modifiable by lifestyle and ACE inhibitors.
Why the study?
Elevated pulse pressure is increasingly recognized as a risk factor for cardiovascular disease, prompting a review of its origin, clinical relevance, and treatment.
This review highlights the mechanisms driving elevated pulse pressure, its role as a cardiovascular risk factor, and potential lifestyle and pharmacological interventions to manage it.
May inform cardiovascular risk stratification in coronary disease; leaves open targeted therapies to lower pulse pressure.
The goal of this study was to review the origin, clinical relevance and treatment of pulse pressure (PP). Elevated PP is increasingly being recognized as a risk factor for cardiovascular, particularly coronary, disease. Pulse pressure is discussed in terms of both Windkessel and distributive models of the arterial circulation. Pulse pressure arises from the interaction of cardiac ejection (stroke volume) and the properties of the arterial circulation. An increased stiffness of the aorta and large arteries leads to an increase in PP through a reduction in arterial compliance and effects on wave reflection. A number of factors are known to influence arterial wall behavior and, therefore, PP. In addition to the effects of aging and blood pressure on arterial wall elasticity, there is some evidence that atherosclerosis, per se, amplifies these effects. Thus, the relationship between PP and coronary disease may be bidirectional. A number of dietary and lifestyle interventions have been shown to modify large artery behavior. These include aerobic exercise training and consumption of n-3 fatty acids. Conversely, strength training is associated with an increase in arterial stiffness and a higher PP. The effects of antihypertensive medication have been extensively studied, but many studies are difficult to interpret because of concomitant change in blood pressure, and to a lesser degree, heart rate. However a number of studies do suggest direct arterial wall effects, particularly for angiotensin-converting enzyme inhibitors. A distributed compliance model of the arterial circulation provides a framework for understanding the causes, effects and potential treatment of elevations in PP.
No takes yet. Share an insight, caveat, or question.
Dart et al. (2001) conducted a review in Elevated pulse pressure. Elevated pulse pressure is a risk factor for cardiovascular disease driven by arterial stiffness, which can be modified by lifestyle interventions and antihypertensive medications like ACE inhibitors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: